Use of Low-dose Quetiapine and the Risk of Major Adverse Cardiovascular Events

18/01/2021
22/02/2024
EU PAS number:
EUPAS38508
Study
Planned
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Quetiapine_CVD_protocol_180121

English (146.1 KB - PDF) View document
Updated protocol

quetiapine_cvd_protocol_27oct21

First published: 22/02/2024
English (193.21 KB - PDF) View document
Study results
Study report
Other information